Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Board/Management Information 2024

Feb 20, 2024

5262_mang_2024-02-20_359bf528-5def-4873-8571-3f62a7c39ebc.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7679D

GSK PLC

20 February 2024

GSK plc

Director Declaration

GSK plc (the 'Company') announces, pursuant to the Financial Conduct Authority's Listing Rule 9.6.14(2), that Julie Brown, Executive Director and Chief Financial Officer of the Company, has been appointed as a Non-Executive Director of Diageo plc with effect from 5 August 2024.

V A Whyte

Company Secretary

20 February 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNURVWRSKUUURR